How big is the Cancer Vaccines Market?

The Cancer Vaccines Market size is expected to reach USD 9.67 billion in 2024 and grow at a CAGR of 10.31% to reach USD 15.80 billion by 2029. Read More

What is the current Cancer Vaccines Market size?

In 2024, the Cancer Vaccines Market size is expected to reach USD 9.67 billion. Read More

Who are the key players in Cancer Vaccines Market?

OSE Immunotherapeutics, GlaxoSmithKline PLC, F Hoffmann-La Roche AG (Genentech), Moderna Inc. and Merck & Co. Inc. are the major companies operating in the Cancer Vaccines Market. Read More

Which is the fastest growing region in Cancer Vaccines Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Cancer Vaccines Market?

In 2024, the North America accounts for the largest market share in Cancer Vaccines Market. Read More

What years does this Cancer Vaccines Market cover, and what was the market size in 2023?

In 2023, the Cancer Vaccines Market size was estimated at USD 8.77 billion. The report covers the Cancer Vaccines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Cancer Vaccines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Cancer Vaccines Market Share

Statistics for the 2023 & 2024 Cancer Vaccines market share, created by Mordor Intelligence™ Industry Reports. Cancer Vaccines share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Cancer Vaccines Industry

The cancer vaccine market is consolidated and consists of a few major players. Market players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, mergers, and acquisitions. Companies, like AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline, Roche, and Merck & Co. Inc., OSE Immunotherapeutics, Sanofi, and Moderna, among others, hold substantial shares in the cancer vaccine market.